Articles with "non valvular" as a keyword



Photo by nci from unsplash

Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry

Sign Up to like & get
recommendations!
Published in 2019 at "Clinical Cardiology"

DOI: 10.1002/clc.23176

Abstract: Atrial fibrillation (AF) is an important preventable cause of stroke. Anticoagulation (AC) therapy can reduce this risk. However, prescribing patterns and outcomes in patients with non‐valvular AF (NVAF) from Latin American countries are poorly described. read more here.

Keywords: atrial fibrillation; non valvular; american countries; stroke prevention ... See more keywords

Association Between Changes in Heart Rate and Adverse Events in Patients With Non‐Valvular Atrial Fibrillation: A Post Hoc Analysis of the J‐RHYTHM Registry

Sign Up to like & get
recommendations!
Published in 2025 at "Clinical Cardiology"

DOI: 10.1002/clc.70122

Abstract: We previously reported that the heart rate (HR) at the time closest to an event or at the last visit during the follow‐up period (HR‐end) was more closely associated with adverse events (AEs) than baseline… read more here.

Keywords: adverse events; patients non; valvular atrial; atrial fibrillation ... See more keywords

Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Thrombosis and Thrombolysis"

DOI: 10.1007/s11239-019-01934-6

Abstract: The approved dose of oral anticoagulant rivaroxaban for patients with non-valvular atrial fibrillation (NVAF) in Japan is 15 mg once daily (od) in patients whose creatinine clearance is ≥ 50 mL/min, but recent real-world studies have demonstrated… read more here.

Keywords: atrial fibrillation; real world; valvular atrial; non valvular ... See more keywords

Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of Thrombosis and Thrombolysis"

DOI: 10.1007/s11239-024-02976-1

Abstract: There is a paucity of real-world studies examining the risks of stroke/systemic embolism (SE) and major bleeding (MB) among non-valvular atrial fibrillation (NVAF) patients switching from warfarin to a direct oral anticoagulant (DOAC). This retrospective… read more here.

Keywords: rivaroxaban; risk; switching warfarin; dabigatran rivaroxaban ... See more keywords

Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis

Sign Up to like & get
recommendations!
Published in 2018 at "American Journal of Cardiovascular Drugs"

DOI: 10.1007/s40256-018-0293-0

Abstract: IntroductionEffectiveness of oral anticoagulants (OACs) is critically dependent on patients’ adherence to intake regimens. We studied the relative impact of attributes related to effectiveness, safety, convenience, and costs on the value of OAC therapy from… read more here.

Keywords: atrial fibrillation; valvular atrial; non valvular; therapy ... See more keywords
Photo from wikipedia

Association of left atrial deformation indices with left atrial appendage thrombus in patients with non valvular atrial fibrillation

Sign Up to like & get
recommendations!
Published in 2020 at "Indian Heart Journal"

DOI: 10.1016/j.ihj.2020.07.010

Abstract: Aim Assessment of the value of left atrial deformation indices for prediction of left atrial appendage functioning patients with non-valvular atrial fibrillation. Method The study included 250 patients with non-valvular atrial fibrillation and normal left… read more here.

Keywords: sec; patients non; group; non valvular ... See more keywords

Real-world persistence with direct oral anticoagulants (DOACs) in naïve patients with non-valvular atrial fibrillation.

Sign Up to like & get
recommendations!
Published in 2019 at "International journal of cardiology"

DOI: 10.1016/j.ijcard.2019.04.061

Abstract: BACKGROUND Anticoagulation therapy is central for the management of stroke in patients with non-valvular atrial fibrillation (NVAF). Persistence with oral anticoagulation is essential to prevent thromboembolic complications. METHODS We performed a population-based retrospective cohort study… read more here.

Keywords: valvular atrial; oral anticoagulants; patients non; non valvular ... See more keywords

Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation.

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of cardiology"

DOI: 10.1016/j.jjcc.2016.11.009

Abstract: BACKGROUND Adherence to medication plays an important role in the prevention of morbidity and mortality in non-valvular atrial fibrillation (NVAF) patients. The aim of this study is to assess adherence to medication and risk factors… read more here.

Keywords: valvular atrial; non valvular; non adherence; adherence medication ... See more keywords

Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of cardiology"

DOI: 10.1016/j.jjcc.2018.12.013

Abstract: BACKGROUND The effectiveness and safety of dabigatran etexilate (DE) have not been elucidated thoroughly in clinical practice for Japanese patients with non-valvular atrial fibrillation (NVAF). In particular, those of DE at a reduced dose due… read more here.

Keywords: effectiveness safety; clinical practice; patients non; non valvular ... See more keywords

Timing to start anticoagulants after acute ischemic stroke with non-valvular atrial fibrillation

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of the Neurological Sciences"

DOI: 10.1016/j.jns.2019.116582

Abstract: OBJECTIVE To identify timing for initiation of anticoagulation therapy in acute ischemic stroke (AIS) with non-valvular AF as regards safety and efficacy by detecting the rate of intracranial haemorrhage (ICH) and recurrent ischemic symptoms (RIS)… read more here.

Keywords: ischemic stroke; group; non valvular; association ... See more keywords

Discrepancies between the use of MDRD-4 IDMS and CKD-EPI equations, instead of the Cockcroft-Gault equation, in the determination of the dosage of direct oral anticoagulants in patients with non-valvular atrial fibrillation.

Sign Up to like & get
recommendations!
Published in 2018 at "Medicina clinica"

DOI: 10.1016/j.medcli.2017.06.003

Abstract: BACKGROUND AND OBJECTIVE Direct oral anticoagulants (DOACs) require dose adjustment according to estimated clearance creatinine (eClCr) using the Cockcroft-Gault (CG) equation. There are discrepancies with the equations that estimate glomerular filtration rate (eGFR). We analyse… read more here.

Keywords: valvular atrial; patients non; non valvular; mdrd idms ... See more keywords